NetworkNewsBreaks Archive - Page 889 of 2232

TuesdayMay 24, 2022 3:32 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in New ‘TechTalks’ Video

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biotechnology and other industries. The company today announced that Emerging Technology Insider, a leading global source for business and financial opportunities of technology companies, has released a new “TechTalks” video interview featuring its CEO and Founder Richard T. Schumacher. The piece focuses on PBI’s recent initiation of an Early Access Program for its revolutionary Ultra Shear Technology(TM) (“UST(TM)”) platform for the processing of oil-based active ingredients into water-soluble, highly bioavailable nanoemulsions. The TechTalks video…

TuesdayMay 24, 2022 3:00 pm

NetworkNewsBreaks – CWCBExpo New York’s ‘In Conversation With’ Series to Feature Tremaine Wright

Tremaine Wright will be featured in a special “In Conversation with…” presentation at CWCBExpo New York on Friday, June 3. Wright, the chairwoman of the New York State Cannabis Control Board, is responsible for regulatory and tax policies regarding medical and adult-use cannabis in New York State. In the one-on-one conversation hosted by Gia Moron, president of Women Grow and founder and CEO of GVM Communications, Wright will provide an exclusive update on all aspects of New York’s legal cannabis program. CWCBExpo New York, slated to take place June 2-4, 2022, is the longest running cannabis event at the Javits…

TuesdayMay 24, 2022 2:51 pm

NetworkNewsBreaks – HouseBit Corp. Unveils New Ownership, Occupancy Model with Completion of First Fully Tokenized Property in Miami

HouseBit, based in Miami, has completed the first fully digital, real estate tokenization on a property in downtown Miami; the transaction used cryptographic decentralized blockchain technology. Miami-based International Realty Group, a Florida- licensed, full-service boutique real estate brokerage specializing in the luxury market, was also involved in the transaction. According to the announcement, the tokenization involved the combination of HouseBit’s patent-pending technology and a land trust created specifically for the property, which issued 1,000 ownership tokens, including a single occupancy non-fungible token (“NFT”), which provides the right to occupy the property. The other ownership tokens represented proportional ownership in the…

TuesdayMay 24, 2022 2:19 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Shares Company Presentations, Keynote Addresses from 2022 Sequire Fintech Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, is making replays from its 2022 Sequire Fintech Conference presentation available. SRAX hosted the virtual investor event on May 19, 2022. During the conference, premier fintech stock market companies made key presentations to investor attendees; industry experts also provided keynote addresses during the event. The event was sponsored by Apex Fintech Solutions, Banxa Holdings Inc., Usio Inc. and Newtek Business Services Corp. According to the announcement, those interested can view the keynote address, panel discussions and company presentations…

TuesdayMay 24, 2022 2:08 pm

NetworkNewsBreaks – HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) (TSX.V: HIVE) (FSE: HBF) Announces 5:1 Share Consolidation

HIVE Blockchain Technologies (NASDAQ: HIVE) (TSX.V: HIVE) (FSE: HBF) today announced that, further to its May 10 press release, the company will be proceeding with the consolidation of its common shares on the basis of five pre-consolidation common shares for one post-consolidation common share. The common shares will commence trading on the TSX Venture Exchange (“TSXV”) and Nasdaq on a post-consolidation basis effective at the opening of the market on May 24, 2022. Completion of the consolidation is subject to receipt of all necessary regulatory approvals, including TSXV approval and pursuant to the Business Corporations Act (British Columbia) and the…

TuesdayMay 24, 2022 1:13 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Announces Issuance of Circular, Incentive Plan and Granting of PSUs

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today announced that it has issued a management information circular in respect of the annual general meeting of shareholders to be held on June 23, 2022. The circular is available on the company’s profile on SEDAR at www.SEDAR.com. In addition, to provide added flexibility to its executive compensation program, FSD Pharma on May 16, 2022, adopted an equity incentive plan (the “EIP”) pursuant to which it may grant shares, restricted share units, performance share units (“PSUs”) and…

TuesdayMay 24, 2022 11:46 am

NetworkNewsBreaks – Global PayEX Participates at Finovate Spring 2022, Shines Spotlight on Proprietary AR Solutions

Global PayEX, a U.S.-headquartered B2B fintech that powers large corporations and mid-sized companies to bring working capital efficiencies via accounts receivable (“AR”) and accounts payable (“AP”) automation, participated in the Finovate Spring 2022 event. At the event, the company focused on its end-to-end, native-cloud, data-driven AR software solutions. According to the announcement, the company, which is backed by J.P. Morgan, has processed more than $50 billion in transactions. Its proprietary artificial intelligence (“AI”) and machine-learning (“ML”) offerings have built a reputation for delivering remarkable actionable insights for users, which include global multinationals 3M, Bridgestone, Huhtamaki, Stanley Black & Decker, GlaxoSmithKline…

TuesdayMay 24, 2022 11:29 am

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Schedules Conference Call to Discuss Q1 2022 Financial Results, Enters Acquisition Agreement

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, will releases its 2022 first-quarter financial results after market close today, May 24, 2022. In addition, the company will host a Zoom conference call to discuss company financial results and corporate updates on Wednesday, May 25. The Zoom event will begin at 10 a.m. ET. EverGen CEO Chase Edgelow will lead the call. In addition, EverGen signed a definitive agreement to acquire 50% interest in a portfolio of RNG development projects, known as Project Radius and owned by Northeast Renewables LP. The acquisition gives EverGen entry into the…

TuesdayMay 24, 2022 10:37 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at H.C. Wainwright Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its CEO John Climaco will be participating at the H.C. Wainwright Global Investment Conference. The event is slated to take place May 23-26, 2022, virtually and in-person in Miami, Florida. A video webcast of Climaco’s presentation is now accessible for viewing on-demand for registered attendees and will be available on the company’s website. Following the event, the webcast replay will be archived for 90 days. In addition, CNSP management will be…

MondayMay 23, 2022 1:49 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Among Most Powerful of Chemotherapy Drugs

CNS Pharmaceuticals’ (NASDAQ: CNSP) novel anthracycline Berubicin, which has been developed to treat diseases with unmet need such as the deadly glioblastoma (“GBM”), appears to be the first anthracycline chemotherapy agent to successfully cross the blood-brain barrier in targeting tumors of the central nervous system. “Berubicin was the drug candidate subject of a small-scale phase 1 clinical trial in 2006 that evaluated its safety, which was notable because one of the two dozen evaluated patients emerged cancer-free and has remained so over the subsequent 16 years. Nearly half of the trial’s patients experienced a statistically significant improvement in clinical benefit.…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks